Kenner C Rice Selected Research

rebemide

1/2012	Interaction between Mu and Delta Opioid Receptor Agonists in an Assay of Capsaicin-Induced Thermal Allodynia in Rhesus Monkeys.
10/2006	Effects of the selective delta opioid agonist SNC80 on cocaine- and food-maintained responding in rhesus monkeys.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenner C Rice Research Topics

Disease

38	Pain (Aches) 04/2022 - 01/2003
26	Hyperalgesia 04/2022 - 03/2006
18	Substance-Related Disorders (Drug Abuse) 11/2021 - 01/2004
11	Opioid-Related Disorders (Opiate Addiction) 02/2022 - 01/2003
11	Neuralgia (Stump Neuralgia) 01/2022 - 11/2007
11	Inflammation (Inflammations) 01/2021 - 06/2002
10	Alcoholism (Alcohol Abuse) 11/2021 - 12/2007
7	Obesity 01/2018 - 01/2004
7	Cocaine-Related Disorders (Cocaine Addiction) 03/2016 - 03/2002
6	Chronic Pain 05/2021 - 03/2006
6	Body Weight (Weight, Body) 01/2018 - 08/2012
6	Hypersensitivity (Allergy) 01/2018 - 03/2006
5	Hyperthermia 01/2019 - 05/2004
4	Neuroinflammatory Diseases 04/2022 - 01/2019
4	Memory Disorders (Memory Loss) 01/2021 - 01/2018
4	Infections 11/2019 - 01/2003
4	Seizures (Absence Seizure) 01/2019 - 02/2006
4	Neoplasms (Cancer) 01/2018 - 11/2005
4	Acute Pain 02/2015 - 07/2005
3	Premature Birth (Birth, Premature) 04/2020 - 11/2016
3	Weight Loss (Weight Reduction) 01/2019 - 06/2002
3	Schizophrenia (Dementia Praecox) 01/2018 - 09/2002
3	Bulimia (Binge Eating) 10/2017 - 09/2012
3	Feeding and Eating Disorders (Eating Disorder) 10/2017 - 01/2004
3	Respiratory Insufficiency (Respiratory Failure) 10/2014 - 11/2009
2	Peripheral Nerve Injuries 01/2022 - 01/2018
2	Fetal Death 01/2020 - 11/2016
2	Perinatal Death 01/2020 - 11/2016
2	Autistic Disorder (Autism) 01/2019 - 09/2009
2	Migraine Disorders (Migraine) 01/2017 - 02/2015
2	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 12/2014

Drug/Important Bio-Agent (IBA)

32	Opioid Analgesics (Opioids)IBA 04/2022 - 09/2002
17	Morphine (MS Contin)FDA LinkGeneric 04/2022 - 01/2003
14	Analgesics (Analgesic Drugs)IBA 04/2022 - 11/2005
13	Toll-Like Receptor 4IBA 01/2021 - 07/2008
13	Pharmaceutical PreparationsIBA 11/2018 - 08/2007
11	Naltrexone (ReVia)FDA LinkGeneric 01/2021 - 07/2008
10	Opioid Receptors (Opioid Receptor)IBA 04/2022 - 03/2006
10	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 09/2009
8	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2009
8	4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA 01/2020 - 11/2005
8	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 05/2006
7	VaccinesIBA 02/2022 - 09/2014
7	Naloxone (Narcan)FDA LinkGeneric 04/2020 - 07/2008
6	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2019 - 04/2005
6	Interleukin-6 (Interleukin 6)IBA 01/2018 - 08/2007
5	Fentanyl (Sublimaze)FDA LinkGeneric 04/2022 - 04/2014
5	Heroin (Diamorphine)IBA 02/2022 - 01/2017
5	LigandsIBA 10/2021 - 03/2002
5	R 121919IBA 01/2018 - 04/2009
5	Cocaine (Cocaine HCl)IBA 03/2016 - 10/2006
5	Corticotropin-Releasing HormoneIBA 01/2016 - 06/2002
4	Minocycline (Cyclops)FDA LinkGeneric 04/2022 - 10/2014
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 11/2007
4	Methadone (Dolophine)FDA LinkGeneric 11/2020 - 01/2012
4	Narcotic Antagonists (Opioid Antagonists)IBA 04/2020 - 07/2008
4	volinanserinIBA 01/2019 - 05/2004
4	antalarminIBA 01/2018 - 06/2002
4	Capsaicin (Zostrix)FDA Link 01/2018 - 09/2008
4	Nalbuphine (Nubain)FDA LinkGeneric 01/2018 - 11/2010
4	CRF receptor type 1IBA 10/2017 - 12/2007
3	InflammasomesIBA 04/2022 - 01/2016
3	HaptensIBA 02/2022 - 02/2016
3	Synthetic CathinoneIBA 11/2021 - 11/2014
3	Dynorphins (Dynorphin)IBA 05/2021 - 03/2006
3	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2020 - 01/2017
3	CytokinesIBA 11/2019 - 08/2007
3	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2019 - 05/2004
3	CorticosteroneIBA 01/2018 - 06/2002
3	lorcaserinIBA 01/2018 - 12/2015
3	NeuropeptidesIBA 01/2018 - 11/2012
3	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 10/2017 - 01/2004
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2016
3	RimonabantIBA 10/2014 - 11/2013
3	CannabinoidsIBA 09/2014 - 11/2013
3	AcidsIBA 02/2014 - 10/2010
3	GABA-B ReceptorsIBA 03/2013 - 10/2010
3	delta Opioid Receptors (delta Opioid Receptor)IBA 04/2012 - 11/2005
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2007 - 03/2002
2	norbinaltorphimineIBA 05/2021 - 06/2010
2	Sigma-1 ReceptorIBA 01/2021 - 01/2015
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2021
2	1- (2- (3,4- dichlorophenyl)ethyl)- 4- methylpiperazineIBA 01/2021 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 02/2006
2	Toll-Like Receptor 2IBA 01/2021 - 05/2012
2	AntibodiesIBA 11/2020 - 09/2014
2	Platelet Activating FactorIBA 04/2020 - 01/2020
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2019 - 04/2005
2	Oxycodone (Oxycontin)FDA LinkGeneric 01/2018 - 02/2016
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2018 - 08/2013
2	SaltsIBA 01/2018 - 04/2015
2	20,21-epoxyresibufogenin-3-formateIBA 01/2018 - 11/2010
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2018 - 11/2009
2	Methamphetamine (Desoxyn)FDA LinkGeneric 06/2017 - 02/2016
2	ibudilastIBA 01/2017 - 04/2014
2	Serotonin ReceptorsIBA 01/2016 - 04/2011

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2007
6	Analgesia 04/2022 - 11/2007
4	Self Administration (Administration, Self) 11/2021 - 12/2007
2	Injections 10/2017 - 08/2014